Advanced Research Projects Agency for Health logo
ARPA-H

ARPA-H Initiatives & Sprints

Runs fast-turnaround health technology opportunities in United States for high-potential exploratory science and engineering.

OpenAdvanced Research Projects Agency for HealthUnited States

ARPA-H Initiatives and Sprints are the agency's accelerated funding tracks, designed to move from proposal submission to executed agreement significantly faster than the standard Program ISO pipeline. Unlike Program ISOs, which target a single well-defined technical goal over multiple years, Initiatives bundle a range of topics under a common acceleration or integration framework and are structureโ€ฆ

Topics that span the ARPA-H mission, structured as exploratory or accelerator-style investments. Current example: TIGAR (Technology InteGrator and AcceleratoR) Exploratory Topic.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.Rolling
Next deadlineiThe next date applications are due. Rolling means you can apply any time.Rolling
Decision timeiTypical time from the deadline to the funder's decision.16 weeks
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Cooperative agreement
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.$100M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides โ†’
NIH Common Fund logo
Open

NIH Common Fund Venture Program โ€” Open Funding (Seed)

๐Ÿ‡บ๐Ÿ‡ธNIH Common Fund ยท United States

Supports high-potential short- to medium-range initiatives that can seed major breakthroughs.

BiotechMedtech+3
$15M
National Institutes of Health logo
Open

Assay Validation of High Quality Markers for Clinical Studies in Cancer

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds two years of analytical validation then three of clinical validation for a cancer biomarker assay that already works on human samples.

BiotechMedtech+1
Oct'26
Defense Health Agency logo
Open

Defense Health Agency SBIR Phase I

๐Ÿ‡บ๐Ÿ‡ธDHA ยท United States

Funds United States defense medical innovators at feasibility stage for life-changing military health technologies.

DefenseMedtech+2
$323K
Defense Health Agency logo
Open

Defense Health Agency SBIR Phase II

๐Ÿ‡บ๐Ÿ‡ธDHA ยท United States

Supports United States defense health teams maturing validated medical technologies toward practical military use.

DefenseMedtech+2
$2.2M
National Institutes of Health logo
Open

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds the first human trials of a novel-mechanism psychiatric drug or a novel neuromodulatory device, with milestones gating each step.

BiotechNeurotech+1
Oct'27
Defense Advanced Research Projects Agency logo
Between cycles

DARPA BTO Office-wide BAA

๐Ÿ‡บ๐Ÿ‡ธDARPA ยท United States

Funds United States convergence work in biology, neurotechnology, and synthetic biology for strategic defense purposes.

DefenseBiotech+3
$1M โ€“ $30M